4 April 2025 false No description of principal activity Taxfiler 2024.6 16364641 business:PrivateLimitedCompanyLtd 2025-04-04 2026-04-30 16364641 2025-04-03 16364641 2025-04-04 2026-04-30 16364641 business:AuditExemptWithAccountantsReport 2025-04-04 2026-04-30 16364641 business:FilletedAccounts 2025-04-04 2026-04-30 16364641 2026-04-30 16364641 core:WithinOneYear 2026-04-30 16364641 core:ShareCapital core:PreviouslyStatedAmount 2026-04-30 16364641 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-04-30 16364641 core:PreviouslyStatedAmount 2026-04-30 16364641 business:SmallEntities 2025-04-04 2026-04-30 16364641 business:Director1 2025-04-04 2026-04-30 16364641 countries:EnglandWales 2025-04-04 2026-04-30 16364641 business:RegisteredOffice 2025-04-04 2026-04-30 iso4217:GBP xbrli:pure
Aframerx Limited Statement of financial position as at 30 April 2026
2026
Notes
£
Current assets
Inventories
3,332
Debtors
4
1
Cash at bank and in hand
2,773
6,106
Creditors: amounts falling due within one year
5
(102,295)
Net current liabilities
(96,189)
Net liabilities
(96,189)
Capital and reserves
Called up share capital
1
Profit and loss account
(96,190)
Shareholders' funds
(96,189)
For the period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 16 May 2026 and were signed on its behalf by
Taiwo Obiyele Director Company Registration No. 16364641
- 1 -
Aframerx Limited Notes to the Accounts for the period from 4 April 2025 to 30 April 2026
1
Statutory information
Aframerx Limited is a private company, limited by shares, registered in England and Wales, registration number 16364641. The registered office is 686 Bolton Road, Pendlebury, Swinton, Manchester, Lancashire, M27 8FH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2026
£
Amounts falling due within one year
Other debtors
1
5
Creditors: amounts falling due within one year
2026
£
Loans from directors
101,845
Accruals
450
102,295
6
Average number of employees
During the period the average number of employees was 0.
- 2 -